Диссертация (1174276), страница 23
Текст из файла (страница 23)
8. – P. 576-581.134. Huang, Y.S. Impact of chronic obstructive pulmonary diseases on leftventricular diastolic function in hospitalized elderly patients / Y.S. Huang, Y.C. Feng, J.Zhang // Clin. Interv. Aging. – 2015. – Vol. 10. – Р. 81-87.135. Imai, К. Prediction of Congestive Heart Failure in Patients with NonValvular Atrial Fibrillation / К. Imai // Intern Med. – 2014. - Vol. 53. – P. 7-12.136. Jaiswal, A.
Challenges in the Management of Patients with ChronicObstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction / A.Jaiswal, A. Chichra, V. Q. Nguyen, et al. // Curr. Heart Fail. Rep. – 2016. – Vol. 13, N.1. – Р. 30-36.137. Kao, D. P. Characterization of subgroups of heart failure patients withpreserved ejection fraction with possible implications for prognosis and treatment147response / D.P.
Kao, J. D. Lew, I. S. Anand, et al. // Eur J Heart Fail. – 2015. – Vol. 17,N. 9. – Р. 925-935.138. Kara, K. B-type natriuretic peptide for incident atrial fibrillation – The HeinzNixdorf Recall / K. Kara, M. Geisel, S. Mohlenkamp, et al.
// J. Cardiol. – 2015. - Vol.65, N. 6. – P. 453-458.139. Kelly, J.P. Statins and Exercise Training Response in Heart Failure Patients:Insights From HF-ACTION / J. P. Kelly, A. Dunning, P. J. Schulte, et al. // JACC HeartFail. – 2016. – Vol. 4, N. 8.
– Р. 617-624.140. Khan, M.A. The importance of interactions between atrial fibrillation andheart failure / M. A. Khan, D. K. Satchithananda, M. A. Mamas // Clin Med (Lond). –2016. – Vol. 16, N. 3. – Р. 272-276.141. Kim, H. Prognostic Value of Tricuspid Annular Tissue Doppler Velocity inHeart Failure with Atrial Fibrillation / H.
Kim, C. Jung, H.J. Yoon, et al. // J. Am. Soc.Echocardiogr. – 2012. - Vol. 25. – P. 436-443.142. Kirkwood, A. Surfactant protein D: not just for the lung anymore / A.Kirkwood // Am. J. Physiol. Heart Circ. Physiol. – 2008. - Vol. 294, N.5 – P. H1994.143. Kodani, E. Effect of carvedilol on reduction in heart rate in patients withchronic atrial fibrillation / E. Kodani, S.
Matsumoto, O. Igawa, et al. // J. Clin. Med.Res. – 2013. - Vol. 5 – P. 451-459.144. Kubba, S. Methods for Evaluating Right Ventricular Function andVentricular-Arterial Coupling / S. Kubba, C.D. Davila, P.R. Forfia // Prog. Cardiovasc.Dis. – 2016. – Vol. 59, N. 1. – Р. 42-51.145. Kubota, Y. Impact of β-blocker selectivity on long-term outcomes incongestive heart failure patients with chronic obstructive pulmonary disease / Y.Kubota, K. Asai, E.
Furuse, et al. // Int. J. Chron. Obstruct. Pulmon. Dis. – 2015. – Vol.10. – Р. 515-523.146. Lai, Y.C. Pulmonary arterial hypertension: the clinical syndrome / Y.C. Lai,K.C. Potoka, H.C. Champion, et al. // Circ. Res. – 2014. – Vol. 115, N. 1. – Р. 115-130.147. Lainchbury, J.G. N-terminal pro-B-type natriuretic peptide-guided treatmentfor chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted148Treatment To Lessen Serial Cardiac Readmissions and Death) trial / J.G. Lainchbury,R.W.
Troughton, K.M. Strangman, et al. // J. Am. Coll. Cardiol. – 2009. – Vol. 55, N.1.– Р. 53-60.148. Lam, C.S. Epidemiology and clinical course of heart failure with preservedejection fraction / C.S. Lam, E. Donal, E. Kraigher-Krainer, R.S. Vasan // Eur. J. HeartFail. – 2011.
– Vol. 13, N. 1. – Р. 18-28.149. Lang, R.M. EAE / ASE Recommendations for Image Acquisition andDisplay Using Three-Dimensional Echocardiography / R.M. Lang, L.P. Badano, W.Tsang, et al. // Eur. Heart J. Cardiovasc. Imaging. – 2012. – Vol. 13, N 1. – Р. 1–46.150. Lang, R.M. Guidelines and standards. Recommendations for CardiacChamber Quantification by Echocardiography in Adults: An Update from the AmericanSociety of Echocardiography and the European Association of Cardiovascular Imaging /R.M. Lang, L.P. Badano, V. Mor-Avi, et al.
// J. Am. Soc. Echocardiogr. – 2015. – Vol.28, N.1. – Р. 1 - 39.151. Laribi, S. Trends in death attributed to heart failure over the past twodecades in Europe / S. Laribi, A. Aouba, M. Nikolaou, et al. // Eur. J. Heart Fail. –2012. – Vol. 14, N. 3.
– Р. 234 - 239.152. Lewicka, E. Plasma biomarkers as predictors of recurrence of atrialfibrillation / E. Lewicka, J. Dudzinska-Gehrmann, A. Dabrowska-Kugacka, et al. //Polskie archiwum medycyny wewnetrznej. – 2015. – Vol. 125, N. 6. – Р. 424 - 433.153. Li, J. Airflow obstruction, lung function, and incidence of atrial fibrillation:the Atherosclerosis Risk in Communities (ARIC) study / J.
Li, S.K. Agarwal, A.Alonso, et al. // Circulation. – 2014. – Vol. 129, N. 9. – Р. 971-980.154. Lindenfeld, J. Comprehensive heart failure practice guideline / J. Lindenfeld,N.M. Albert, J.P. Boehmer, et al. // J. Card. Fail. – 2010. – Vol. 16, N. 6. – Р.e1- 194.155. Linssen, G.C. Clinical and prognostic effects of atrial fibrillation in heartfailure patients with reduced and preserved left ventricular ejection fraction / G.C.Linssen, M. Rienstra, T. Jaarsma, et al.
// Eur. J. Heart Fail. – 2011. – Vol. 13, N. 10 –Р. 1111-1120.149156. Maggioni, A.P. Management of atrial fibrillation still suboptimal in Europe /A.P. Maggioni // European Society of Cardiology (ESC) . – 2013.157. Majos, E. The right ventricle in patients with chronic heart failure and atrialfibrillation / E. Majos, R. Dąbrowski, H.
Szwed, et al. // Cardiol. J. – 2013. – Vol. 20,N. 3. – Р. 220-226.158.Maisel,W.H.Atrialfibrillationin heartfailure: epidemiology,pathophysiology, and rationale for therapy / W.H. Maisel, L.W. Stevenson // Am. J.Cardiol. – 2003. – Vol. 91, N. 6A. – Р. 2D-8D.159. Mannino, D.M. Plasma fibrinogen as a biomarker for mortality andhospitalized exacerbations in people with COPD / D.M. Mannino, R. Tal-Singer, D.A.Lomas, et al. // Chronic Obstr. Pulm. Dis.
(Miami). – 2015. – Vol. 2. – Р. 23-34.160. Martiniuc, C. Angiotensin converting enzyme inhibitors and pulmonaryhypertension / C. Martiniuc, A. Braniste, T. Braniste // Rev. Med. Chir. Soc. Med. Nat.Iasi. – 2012. – Vol. 116, N. 4. – Р. 1016-1020.161. Melenovsky, V. Left atrial remodeling and function in advanced heart failurewith preserved or reduced ejection fraction / V. Melenovsky, S.J. Hwang, M.M.Redfield, et al. // Circ.
Heart Fail. – 2015. – Vol. 8. – Р. 295-303.162. Melnichenko, O.V. Factors Associated with the Development of AtrialFibrillation in Chronic Obstructive Pulmonary Disease / O.V. Melnichenko, A.A.Nekrasov, A.N. Kuznetsov // Int. J. Biomed. – 2011. – Vol. 1, N. 2 – Р. 71-73.163. Meune, C.
Mid-regional pro atrial natriuretic peptide allows the accurateidentification of patients with atrial fibrillation of short time of onset: a pilot study / C.Meune, A. Vermillet, K. Wahbi, et al. // Clin. Biochem. – 2011. – Vol. 44, N. 16. – Р.1315-1319.164. McManus, D.D.
Atrial fibrillation and outcomes in heart failure withpreserved versus reduced left ventricular ejection fraction / D.D. McManus, G. Hsu,S.H. Sung, et al. // J. Am. Heart Assoc. – 2013. – Vol. 2, N. 1. – Р. e005694.165. Moro, C. Non-antiarrhythmic drugs to prevent atrial fibrillation / C. Moro,A. Hernandez-Madrid, R. Matia // Am. J. Cardiovasc. Drugs – 2010.
– Vol. 10. – Р.165-173.150166. Nicholson, K. The measurement of multimorbidity / K. Nicholson, J.Almirall, M. Fortin // Health Psychol. – 2019. – Vol. 38, N. 9. – Р. 783-790.167. Obeidat, M. Surfactant protein D is a causal risk factor for COPD: results ofMendelian randomisation / M. Obeidat, X. Li, S. Burgess, et al. // Eur Respir. – 2017. –Vol. 50, N.
5. – Р. 1700657168. Olsson, K.M. Atrial flutter and fibrillation in patients with pulmonaryhypertension / K. M. Olsson, N. P. Nickel, J. Tongers, M. M. Hoeper // Int J Cardiol. –2013. – Vol. 167, N. 5. – Р. 2300-2305.169. O'Meara, E. Circulating biomarkers in patients with heart failure andpreserved ejection fraction / E. O'Meara, de D.S., J.L. Rouleau, et al. // Curr. Heart Fail.Rep. – 2013. – Vol. 10.
– Р. 350–358.170. Potocki, M. Comparison of midregional pro-atrial natriuretic peptide with Nterminal pro-B-type natriuretic peptide in the diagnosis of heart failure/ M. Potocki, T.Breidthardt, T. Reichlin, et al. // J. Intern. Med. – 2010. – Vol. 267, N. 1. – Р. 119-129.171. Rudski, L.G. Guidelines for Echocardiographic Assessment of the rightHeart in Adults: A Report from the American Society of Echocardiography endorsed bythe American Society of Echocardiography a registered branch of the American Societyof Cardiology and the Canadian Society of Echocardiography / L.G.
Rudski, W.W. Lai,J. Afilalo, et al. // J. Am. Soc. Echocardiogr. – 2010. – Vol. 23. – Р. 685-713.172. Sanchis, L. Left atrial dysfunction relates to symptom onset in patients withheart failure and preserved left ventricular ejection fraction / L. Sanchis, L. Gabrielli, R.Andrea et al. // Eur. Heart J. Cardiovasc. Imaging.
– 2015. – Vol. 16, N. 1. – Р. 62-67.173. Savarese, G. Global public health burden of heart failure / G. Savarese, L.H.Lund // Cardiac failure review. – 2017. – Vol. 3, N.1. – P.7.174. Shah, R. Mid-regional pro-atrial natriuretic peptide and proadrenomedullintesting for the diagnostic and prognostic evaluation of patients with acute dyspnoea / R.Shah, Q.
Truong, H. Gaggin, et al. // Eur. Heart J. – 2012. – Vol. 33, N. 17. – Р. 21972205.151175. Shelton, R.J. The Atrial Fibrillation Paradox of Heart Failure / R.J. Shelton,A.L. Clark, G.C. Kaye, J.G. Cleland // Congest. Heart Fail. – 2010. – Vol. 16, N. 1. – Р.3-9.176. Shin, M.S. Attitude toward advance directives and heart failure prognosisamong patients with heart failure: a pilot study / M.S. Shin, J. Kim, S. Heo, et al. // Eur.J. Heart Fail. - 2018.
– Vol. 20. – Р.614-615.177. Sims, M.W. Chronic obstructive pulmonary disease and inhaled steroidsalter surfactant protein D (SP-D) levels: a cross-sectional study / M.W. Sims, R.M. TalSinger, S. Sonja Kierstein, et al. // Respiratory Research. – 2008. – Vol. 9, N. 1. – Р.13.178. Singh, D. Small Airway Disease in Patients with Chronic ObstructivePulmonary Disease / D. Singh // Tuberc. Respir. Dis. (Seoul). – 2017. – Vol. 80, N.
4. –Р. 317 - 324.179. Smit, M.D. The importance of whether atrial fibrillation or heart failuredevelops first / M.D. Smit, M.L. Moes, A.H. Maass, et al. // Eur. J. Heart Fail. – 2012. –Vol. 14. – Р. 1030-1040.180. Smith, D.H. Predicting costs of care in heart failure patients / D.H. Smith,E.S. Johnson, D.K. Blough, et al. // BMC Health Serv. Res. – 2012. – Vol. 12. – Р. 434.181. Stolz, D. Mortality risk prediction in COPD by a prognostic biomarker panel/ D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
